TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events
Item 8.01.
On November 19, 2019 Tonix Pharmaceuticals Holding Corp., a Nevada corporation, (the “Company”), closed its previously announced public offering (the “Offering”) of an aggregate of (i) 547,420 Class A Units (the “Class A Units”), with each Class A Unit consisting of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), one five-year warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of Common Stock at an exercise price equal to $1.94 per share of Common Stock, and one-half of one common warrant to purchase one share of Common Stock at an exercise price equal to $1.94 per share of Common Stock (each, a “Common Warrant”, and collectively, the “Common Warrants”), with each Class A Unit to be offered to the public at a public offering price of $1.94, and (ii) 7,938 Class B Units (the “Class B Units”, and together with the Class A Units, the “Units”), with each Class B Unit offered to the public at a public offering price of $1,000 per Class B Unit and consisting of one share of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred Stock”), with a stated value of $1,000 and convertible into 515.464 shares of Common Stock at the conversion price of $1.94 per share, Warrants to purchase 515.464 shares of Common Stock at an exercise price equal to $1.94 per share of Common Stock, and Common Warrants to purchase 257.732 shares of Common Stock at an exercise price equal to $1.94 per share of Common Stock.
On November 20, 2019, the Company issued a press release announcing the closing of the Offering. A copy of the press release is attached hereto as Exhibit 99.01 and is incorporated herein by reference.
| 99.01 | Press release of Tonix Pharmaceuticals Holding Corp., dated November 20, 2019 |
Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm PRESS RELEASE Tonix Pharmaceuticals Holding Corp. 8-K Exhibit 99.01 Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering NEW YORK,…
To view the full exhibit click here
